Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs

E-ISSN： 1875-5453|17|3|227-236

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.17, Iss.3, 2016-03, pp. : 227-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients

By Glowacki François Lionet Arnaud

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 451-459

Adis International

Access to resources Recommend Favorite

Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients

By Miura Masatomo Satoh Shigeru Kagaya Hideaki Saito Mitsuru Numakura Kazuyuki Tsuchiya Norihiko Habuchi Tomonori

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 977-984

Future Medicine

Access to resources Recommend Favorite

Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 387-394

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 387-394

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

By Eap Chin Buclin Thierry Hustert Elisabeth Bleiber Gabriela Golay Kerry Aubert Anne-Catherine Baumann Pierre Telenti Amalio Kerb Reinhold

European Journal of Clinical Pharmacology, Vol. 60, Iss. 4, 2004-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite